Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rho Kinase Inhibitor for Primary Open‐angle Glaucoma and Ocular Hypertension." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Clinical_assessment_to_screen_for_the_detection_of_oral_cavity_cancer_and_potentially_malignant_disorders_in_apparently_healthy_adults_New. Accessed 28 March 2024.
Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Clinical_assessment_to_screen_for_the_detection_of_oral_cavity_cancer_and_potentially_malignant_disorders_in_apparently_healthy_adults_New. Accessed March 28, 2024.
Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Clinical_assessment_to_screen_for_the_detection_of_oral_cavity_cancer_and_potentially_malignant_disorders_in_apparently_healthy_adults_New
Rho Kinase Inhibitor for Primary Open‐angle Glaucoma and Ocular Hypertension [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Clinical_assessment_to_screen_for_the_detection_of_oral_cavity_cancer_and_potentially_malignant_disorders_in_apparently_healthy_adults_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension
ID - 436789
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Clinical_assessment_to_screen_for_the_detection_of_oral_cavity_cancer_and_potentially_malignant_disorders_in_apparently_healthy_adults_New
DB - Evidence Central
DP - Unbound Medicine
ER -